-
Labubu maker Pop Mart's shares fall 23% despite surging earnings
-
ECB won't be 'paralysed' in face of energy shock: Lagarde
-
Iran hits targets across Middle East after Trump signals talks progress
-
McEvoy says best is to come after breaking long-standing swim record
-
Japan PM asks IEA to prepare additional 'coordinated release' of oil
-
Goat vs gecko: A tiny Caribbean island faces wildlife showdown
-
Japan PM asks IEA chief to prepare additional 'coordinated release' of oil
-
Hungary's hard-pressed LGBTQ people say Orban exit is only half battle
-
Belarus leader visits North Korea for first time
-
'No heavier burden': the decades-long search for Kosovo war missing
-
Exotic pet trade thrives in China despite welfare concerns
-
Iran fires missile salvo after Trump signals progress in talks
-
BTS concert drew 18.4 million viewers, says Netflix
-
OSCE's 'chaotic' Ukraine evacuation put staff at risk: leaked report
-
Top WTO official sounds fertiliser warning over Middle East war
-
France and Brazil weigh up World Cup prospects in glamour friendly
-
Italy hoping to end World Cup pain as play-offs loom
-
Dirty diapers born again in Japan recycling breakthrough
-
Verstappen's Japan GP win streak under threat as Mercedes dominate
-
Crude tumbles, stocks rally on hopes for Iran war de-escalation
-
Sinner powers past Michelsen to reach Miami quarter-finals
-
Gauff outlasts Bencic to reach Miami semi-finals
-
'Hero' Australian dog who saved 100 koalas retires
-
Underdogs chase World Cup berths in Mexico playoff tournament
-
Pope heads to tiny Catholic Monaco
-
Meet the four astronauts set to voyage around the Moon
-
Artemis 2 Moon mission: a primer
-
It's go time: historic Moon mission set for lift-off
-
Denmark's PM Mette Frederiksen, tenacious and tough on migration
-
OpenAI kills Sora video app in pivot toward business tools
-
Danish PM's left-wing bloc wins election, but no majority
-
Brazil court grants house arrest for jailed Bolsonaro
-
Sinner downs Michelsen to reach Miami Open quarter-finals
-
Advantage Arsenal in women's Champions League quarter-final against Chelsea
-
Garner dreams of World Cup glory in bid to replicate England under-21 success
-
New Mexico jury finds Meta liable for endangering children
-
Huge crowd in Buenos Aires marks 50 years since Argentina's coup
-
Oil, stock trading spiked before Trump's Iran remarks
-
Colombia military plane crash death toll rises to 69
-
Trump adds Columbus statue, walkway in latest White House makeover
-
Danish PM's left-wing bloc leads election, but no majority
-
Toronto unveils upgraded World Cup venue after fan scorn
-
Beerensteyn goal gives Wolfsburg edge over Lyon in women's Champions League
-
Gang crackdown carried out without 'abuses,' Guatemalan defense chief says
-
Afghanistan releases detained US citizen
-
Danish PM's left bloc leads election, but no majority
-
'Illustrious' Salah to leave Liverpool at the end of the season
-
Trump says Iran gave US 'gift' linked to Strait of Hormuz
-
US officials downplay controller 'distraction' in New York crash
-
Massive Russian drone attacks kill eight, hit Ukraine UNESCO site
America's biggest pharmacy chains announce abortion pill rollout
America's two biggest pharmacy chains said Friday they will begin dispensing prescription abortion pills in a limited number of states where it's legal.
The move greatly broadens availability of mifepristone, even as a legal case over whether the drug was properly approved two decades ago now rests before the Supreme Court.
A CVS spokesperson told AFP: "We'll begin filling prescriptions for the medication in Massachusetts and Rhode Island in the weeks ahead and will expand to additional states, where allowed by law, on a rolling basis."
Walgreens "expects to begin dispensing within a week" in New York, Pennsylvania, Massachusetts, California, and Illinois, the company said on its website.
"But in the interests of pharmacist and patient safety, we will not disclose the number of sites per state nor identify the pharmacies that are dispensing," it added.
The Food and Drug Administration (FDA) authorized pharmacies to carry mifepristone in January 2023, with Friday's announcements the result of a long certification process.
Mifepristone was initially restricted to use at in-person locations, but was broadened to include mail-delivery during the Covid pandemic.
It works to block a pregnancy and is authorized for use through ten weeks of gestation, while a second drug, misoprostol, provokes bleeding to empty the uterus and was already widely available in pharmacies.
- Election battleground -
The news was hailed by President Joe Biden, who has made protecting reproductive rights a key part of his re-election campaign against the likely Republican candidate Donald Trump.
Trump tipped the balance of the Supreme Court during his own presidency and paved the way for reversal of the national right to abortion.
"With major retail pharmacy chains newly certified to dispense medication abortion, many women will soon have the option to pick up their prescription at a local, certified pharmacy -- just as they would for any other medication," Biden said in a statement.
"The stakes could not be higher for women across America. In the face of relentless attacks on reproductive freedom by Republican elected officials, Vice President Harris and I will continue to fight to ensure that women can get the health care they need."
Susan B. Anthony Pro-Life, a major anti-abortion group, slammed the move, while the Expanding Medication Abortion Access (EMAA) Project called for other major retailers to quickly follow suit.
- Improves access for women -
The US Supreme Court overturned the nationwide right to abortion in 2022, allowing each state to pass its own laws governing the procedure.
Twenty-one states have since banned or moved to restrict abortions to limits tighter than before Roe v Wade, the case law that previously upheld the constitutional right to terminate a pregnancy.
Abortion pills remain illegal in states where the procedure is prohibited. But women who decide to travel to a state where abortion is legal may now find a pharmacy much closer than an abortion clinic.
The Supreme Court will hear arguments on March 26 in a case brought by anti-abortion groups to restrict access to mifepristone, first approved in the year 2000 and used by more than 5.6 million Americans since.
Abortions administered as pills sent in the mail are just as safe and effective as those provided in person, a study published in Nature Medicine found in February.
It looked at data from more than 6,000 abortions using pills supplied by online clinics in 20 states between April 2021 and January 2022, finding there were no "serious adverse events" in 99.8 percent of these medical abortions and no follow-up care was needed in 98 percent of cases.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure -- or ban it outright.
F.AbuZaid--SF-PST